Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All Videos10 Things That Got Me Through TreatmentCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVCalled to CareEducated Patient Sound BitesExercise of the WeekFrom All AnglesOn Demand: WebinarsShortsText a SurvivorThe Breast Cancer BriefingThe Cancer Search Bar
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gallbladder Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Understanding PARP Inhibition in BRCA-Mutated Breast Cancer

EP. 1: Appropriately Diagnosing and Classifying Breast Cancer

December 4th 2018

EP. 2: Considering Treatment for HER2-Negative Breast Cancer

December 4th 2018

EP. 3: BRCA Mutations in HER2-Negative Breast Cancer

December 4th 2018

EP. 4: BRCA+ Breast Cancer: The Advent of PARP Inhibitors

December 4th 2018

EP. 5: Future Role of PARP Inhibition in BRCA+ Breast Cancer

December 4th 2018

EP. 6: Breaking Down the Nature of Breast Cancer

December 4th 2018

EP. 7: Breast Cancer Diagnosis: Addressing Questions and Concerns

December 4th 2018

EP. 8: Treatment Options for HER2-Negative Breast Cancer

December 4th 2018

EP. 9: Benefit of PARP Inhibitors in BRCA+ Breast Cancer

December 4th 2018

EP. 10: BRCA+ Breast Cancer: Managing Patients on PARP Inhibitors

December 4th 2018

EP. 11: Multidisciplinary Management of Breast Cancer

December 4th 2018

EP. 12: Future Treatment Options for BRCA+ Breast Cancer

December 4th 2018
Advertisement
Advertisement

Trending on CURE

1

Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch

2

From Precision Medicine to AI: The Future of Cancer Care

3

How Childhood Cancer Care Has Transformed Over the Years

4

FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer

5

No One Told Us Breast Cancer Treatment Could Take Her Fertility

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.